Related references
Note: Only part of the references are listed.Increasing antimicrobial resistance - an emerging problem in the treatment of shigellosis
S. K. Niyogi
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Design, synthesis, and Multivariate quantitative structure-activity relationship of Salicylanilides-Potent inhibitors of type III secretion in Yersinia
Markus K. Dahlgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Inhibitors of type III secretion in Yersinia:: Design, synthesis and multivariate QSAR of 2-arvisulfonylamino-benzanilides
Anna M. Kauppi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium
Aurel Negrea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Reversal of the antichlaraydial activity of putative type III secretion inhibitors by iron
Anatoly Slepenkin et al.
INFECTION AND IMMUNITY (2007)
Inhibition of type III secretion in Salmonella enterica serovar typhimurium by small-molecule inhibitors
Debra L. Hudson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Identification of a molecular target for the Yersinia protein kinase A
Lorena Navarro et al.
MOLECULAR CELL (2007)
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
Leslie Bailey et al.
FEBS LETTERS (2007)
Structural analysis of a prototypical ATPase from the type III secretion system
Raz Zarivach et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Targeting virulence: a new paradigm for antimicrobial therapy
Anne E. Clatworthy et al.
NATURE CHEMICAL BIOLOGY (2007)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum
Christina M. Marra et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Asymmetric total synthesis of (+)-K0-0509 B: Determination of absolute configuration
Satoshi Tsuchiya et al.
ORGANIC LETTERS (2006)
Small molecule natural products in the discovery of therapeutic agents: The synthesis connection
Rebecca M. Wilson et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
Sandra Muschiol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle
K. Wolf et al.
MOLECULAR MICROBIOLOGY (2006)
Multi-drug resistance in Salmonella enterica:: Efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters
Teresa Quinn et al.
CURRENT DRUG TARGETS (2006)
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation
Sohini Mukherjee et al.
SCIENCE (2006)
Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia
RG Linington et al.
JOURNAL OF NATURAL PRODUCTS (2006)
Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli
A Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Small-molecule inhibitors specifically targeting type III secretion
R Nordfelth et al.
INFECTION AND IMMUNITY (2005)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Antibiotics: where did we go wrong
KM Overbye et al.
DRUG DISCOVERY TODAY (2005)
Antibacterial resistance worldwide: causes, challenges and responses
SB Levy et al.
NATURE MEDICINE (2004)
Blinding trachoma: A disease of poverty
PM Kasi et al.
PLOS MEDICINE (2004)
Where will new antibiotics come from?
C Walsh
NATURE REVIEWS MICROBIOLOGY (2003)
Targeting bacterial virulence:: Inhibitors of type III secretion in Yersinia
AM Kauppi et al.
CHEMISTRY & BIOLOGY (2003)
The Hrp pilus: learning from flagella
SY He et al.
CURRENT OPINION IN MICROBIOLOGY (2003)
Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia
RG Linington et al.
ORGANIC LETTERS (2002)
Yersinia type III secretion:: send in the effectors
GR Cornelis
JOURNAL OF CELL BIOLOGY (2002)
Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure
K Sekiya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Salmonella pathogenicity islands encoding type III secretion systems
I Hansen-Wester et al.
MICROBES AND INFECTION (2001)
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
JL Burns et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
JT Grayston
JOURNAL OF INFECTIOUS DISEASES (2000)
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway:: a mechanism for disruption of actin microfilament structure
U von Pawel-Rammingen et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
